The Perioperative Value of Platelet Counts in Predicting Outcome After Liver Transplantation
NCT ID: NCT01711957
Last Updated: 2012-10-24
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
250 participants
OBSERVATIONAL
2008-01-31
2013-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The investigators aim at evaluating whether postoperative low platelet counts are indicators of short- and long-term outcomes after liver transplantation.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Liver disease and liver transplantation
Patient with end stage liver disease and/or primary liver tumor undergoing liver transplantation
Liver transplantation
Standardized technique of liver transplantation Organ procurement follow the rules of the Swiss transplant society
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Liver transplantation
Standardized technique of liver transplantation Organ procurement follow the rules of the Swiss transplant society
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* End stage liver disease
* Cadaveric-donor liver transplantation
Exclusion Criteria
* Pregnancy
* Living-related liver transplantation
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Zurich
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Dimitri Aristotle Raptis
MD, PhD
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Mickael Lesurtel, M.D., PhD
Role: STUDY_DIRECTOR
University of Zurich
Pierre-Alain Clavien, M.D., PhD
Role: STUDY_CHAIR
University of Zurich
Dimitri A. Raptis, M.D., MSc
Role: PRINCIPAL_INVESTIGATOR
University of Zurich
Emmanuel Melloul, M.D.
Role: PRINCIPAL_INVESTIGATOR
University of Zurich
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University Hospital Zurich, Department of Visceral Surgery and Transplantation
Zurich, Canton of Zurich, Switzerland
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Lesurtel M, Raptis DA, Melloul E, Schlegel A, Oberkofler C, El-Badry AM, Weber A, Mueller N, Dutkowski P, Clavien PA. Low platelet counts after liver transplantation predict early posttransplant survival: the 60-5 criterion. Liver Transpl. 2014 Feb;20(2):147-55. doi: 10.1002/lt.23759. Epub 2013 Nov 21.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
EK-1487
Identifier Type: -
Identifier Source: org_study_id